Finasteride for Alopecia: The Ultimate Guide to Using It Correctly

Finasteride is a commonly prescribed medication for androgenetic alopecia (male pattern hair loss). This guide summarises what the label, published studies and dermatology bodies say about how it works and what to expect from it.

How does finasteride work?

Finasteride blocks the conversion of testosterone into dihydrotestosterone (DHT), a key hormone in androgenetic hair loss. DHT causes susceptible hair follicles to shrink, producing thinner, weaker hair. By reducing DHT levels, finasteride can slow hair loss and, in some men, produce regrowth.

How should I take it?

Treatment with finasteride is straightforward, but it requires commitment. These are the questions readers ask most often.

What is the recommended dosage?

The label dose for androgenetic alopecia is 1 mg once a day. Follow your prescriber's instructions and do not adjust the dosage without consulting them.

When will I see results?

Results are not immediate. In the registration trials, changes in hair density and thickness took roughly 6 to 12 months of continuous use to become visible.

Is it necessary to take it every day?

The 1 mg daily schedule is what the label and the trials used. Studies report that when treatment stops, the benefit gained is gradually lost.

What results can I expect?

Trial data describe modest rather than dramatic change, and outcomes vary between individuals. Some men do not respond at all.

Improvement in hair thickness

Studies report that hairs can become thicker, giving a more voluminous appearance.

Stabilisation of density

Rather than a large increase in the number of hairs, the trials mainly show that further loss slows and the quality of existing hairs improves.

What side effects might you experience?

Like any medication, finasteride can have side effects. Most users in the trials tolerated it, but it is important to know the potential risks. The list below separates the effects reported more often from the rarer ones described in the label and in case reports.

More commonly reported side effects

Decreased libido: Some users report a reduction in sexual desire. This effect tends to appear within the first months of treatment and may diminish with continued use. In some reports it persists after stopping the medication.

Erectile dysfunction: A small percentage of users have reported difficulty achieving or maintaining an erection. Researchers suggest this relates to the reduction of DHT, which plays a role in sexual function. Most reported cases resolve with time or after discontinuing finasteride.

Decreased ejaculation volume: Some men report a decrease in the amount of semen produced during ejaculation. This does not necessarily affect fertility, but it may be noticeable for some individuals.

Breast tenderness or pain: A small percentage of users may develop mild tenderness, swelling, or discomfort in the breast area. This is attributed to hormonal changes, as finasteride slightly affects the balance between androgens and estrogens. If you notice significant changes, such as lumps or persistent pain, see a doctor promptly.

Mood changes: Some studies have linked finasteride to reports of anxiety, depression, and mood swings. These reports are uncommon, but people with a history of mental health problems should watch for psychological changes and seek medical advice if they occur.

Allergic reactions: Although rare, some people report symptoms such as skin rashes, itching, or swelling of the face, lips, or throat. Severe allergic reactions (anaphylaxis) are described as very uncommon but require immediate medical attention.

Less common but serious side effects

Persistent sexual dysfunction (Post-Finasteride Syndrome - PFS): A small subset of users report prolonged sexual, neurological, or psychological symptoms even after stopping the medication. This is still being studied and a causal relationship has not been established.

Breast changes: The manufacturer's label lists male breast cancer among post-marketing reports, meaning cases reported after approval rather than a measured trial rate. Any unusual breast lump, pain or nipple discharge should be checked by a doctor.

Testicular pain: Some users have reported mild to moderate testicular discomfort.

What should you do if you experience side effects? Tell your prescriber or a pharmacist about any side effect you notice, including mild ones, and let them advise you on whether to continue, adjust or stop. Do not make that decision on your own. Seek medical attention straight away for a breast lump, swelling of the face or throat, or thoughts of self-harm.

Is it suitable for everyone?

Finasteride is approved for men. Some women are prescribed it off-label, and only under specialist supervision.

Pregnancy warning: Finasteride can cause abnormalities in the external genitalia of a male foetus. Women who are pregnant, or who may become pregnant, must not take finasteride and must not handle crushed or broken tablets, because the drug can be absorbed through the skin. Whole, coated tablets are safe to handle as long as the coating is intact.

Consistency matters with finasteride, but a result is not guaranteed: a proportion of men see no benefit, and the effect is maintained only while the drug is taken.

Talk to a doctor or pharmacist before starting, stopping or combining finasteride. They can tell you whether it fits your medical history and what to monitor, and they should also know that finasteride lowers PSA readings, which matters for prostate cancer screening.

Sources:

Kaufman, K.D., Olsen, E.A., Whiting, D., Savin, R., DeVillez, R., Bergfeld, W., ... and Roberts, J.L. (1998). Finasteride in the treatment of men with androgenetic alopecia. Journal of the American Academy of Dermatology, 39(4 Pt 1), 578-589. https://pubmed.ncbi.nlm.nih.gov/9777765/

Rossi, A., Cantisani, C., Scarno, M., Trucchia, A., Fortuna, M.C. and Calvieri, S. (2011). Finasteride, 1 mg daily administration on male androgenetic alopecia in different age groups: 10-year follow-up. Dermatologic Therapy, 24(4), 455-461. https://pubmed.ncbi.nlm.nih.gov/21910805/

Gupta, A.K. and Charrette, A. (2014). The efficacy and safety of 5-alpha-reductase inhibitors in androgenetic alopecia: a network meta-analysis and benefit-risk assessment of finasteride and dutasteride. Journal of Dermatological Treatment, 25(2), 156-161. https://pubmed.ncbi.nlm.nih.gov/23768246/

American Academy of Dermatology. (no date). Hair loss: diagnosis and treatment. American Academy of Dermatology Association. https://www.aad.org/public/diseases/hair-loss/treatment

MedlinePlus. (n.d.). Finasteride. U.S. National Library of Medicine. https://medlineplus.gov/druginfo/meds/a698016.html